Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher Closing New Hampshire Plant, Consolidating with North Carolina Operations

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific will be transferring laboratory equipment manufacturing operations from a facility in New Hampshire to North Carolina, the company said.

As a result, 109 positions at the Newington, NH, facility will be eliminated, though 110 jobs will be added to the Asheville, NC, plant, a Thermo Fisher spokesman confirmed. The jobs are being added to help build a new line of temperature controls for scientific equipment.

Separately, 13 laboratory equipment assembly jobs at Thermo Fisher's Portsmouth, NH, site are being transferred to the company's plant in Marietta, Ohio.

The Newington facility is expected to close down by the end of the first quarter 2012, the company said.

"Our leadership team continuously evaluates our geographic footprint in an effort to increase efficiencies and improve our competitive position globally," Thermo Fisher said in a statement. "As part of this evaluation, the dynamics of current market conditions, including costs for energy, labor and raw materials, are assessed.

"We will do everything possible to support the 109 employees at [the Newington] site who are affected and follow all mandated processes," the company added. "Business decisions that result in the loss of jobs are always difficult. However, these actions are designed to strengthen our operations, help us better serve our customers worldwide and provide continued growth opportunities for our 37,000 employees in the long term."

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.